INS and diabetes mellitus: A study indicated that two miRNAs, miR-106b-5p, and miR-222-3p, contribute to bone morrow transplantation (BMT)-induced beta-cell regeneration in mouse models of insulin-deficient diabetes, which may lead to the development of new therapeutic tools for diabetes (90).